VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,512,288 | +8.7% | 56,198 | +21.7% | 0.01% | +14.3% |
| Q2 2023 | $1,390,871 | -44.4% | 46,193 | -40.3% | 0.01% | -50.0% |
| Q1 2023 | $2,501,755 | +121.8% | 77,334 | +96.5% | 0.01% | +27.3% |
| Q4 2022 | $1,127,714 | -38.9% | 39,348 | -48.6% | 0.01% | -50.0% |
| Q3 2022 | $1,845,000 | +28.1% | 76,482 | +45.4% | 0.02% | +37.5% |
| Q2 2022 | $1,440,000 | -41.2% | 52,600 | -17.6% | 0.02% | -23.8% |
| Q1 2022 | $2,450,000 | -7.7% | 63,873 | -22.9% | 0.02% | -4.5% |
| Q4 2021 | $2,654,000 | +15.6% | 82,859 | +6.4% | 0.02% | +10.0% |
| Q3 2021 | $2,295,000 | +6.7% | 77,859 | +23.0% | 0.02% | +5.3% |
| Q2 2021 | $2,151,000 | -20.8% | 63,300 | -24.3% | 0.02% | -5.0% |
| Q1 2021 | $2,717,000 | -0.0% | 83,600 | +10.8% | 0.02% | +122.2% |
| Q4 2020 | $2,718,000 | – | 75,466 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |